involved in achieving this progress:
"As you can no doubt imagine, during the past six months 1 have worked an average of fourteen to sixteen hours daily, including Saturdays, and Sundays, on partial synthesis of cortical steroids."
And then he complains that his other work has received scant attention during this period, "a circumstance which I must remedy at the earliest possible moment."
"Pure" and "applied" chemistry are the two worlds that challenge and consume Julian's energy, the former represented in 51 publications from 1931-1969, the latter an impressive record of 117 Paknts, issued in the US, France, Great Britain, Germany and Australia. Julian's "other work" that he had to neglect while rushing the synthesis of corticoids steroids, such as sex hormones and anti-inflammatories, goes back to his doctoral thesis on alkaloids done at the University of Vienna under the guidance of Professor h s t Spath in 1931. His friend Josef Pikl described Julian's interaction with his Viennese fellow students:
"The two year spent in Austria (1929 Austria ( -1931 had a great influence in developing the personality of Julian. For the first time in his life he was completely at ease, no open or hidden barriers, really an equal among equals. He may even have enjoyed standing a few notches higher than his friends. In the laboratory he was particularly noticed for his nearness, the cleanlmess of his work bench, his ready and contagious laugh, completely uninhibited. AU fifteen other graduate students in the room were his friends."
This friendship with Joseph Pikl matured into a lifelong association and collaboration, after both returned, fust to Howard University in Washington, then to DePauw University in Greencastle, Indiana, where he had entered as a "sub-freshman" from Montgomery, Alabama in 1910. With Pikl he swted a vigorous program on the synthesis of one of the most remarkable alkaloids, viz. physostigmine, the basic active principle from the calabar bean, Physostigma venenosum.
Many alkaloids, such as morphine, nicotine, atropine, quinine, and others are part of the armamentarium of naturally occurring drugs. Physostigmine has a more recent history and has proven its value not only as a therapeutic in controlling glaucoma but also as a tool in elucidating physiological and pharmacological mechanisms (see Table I ). Amcle three: Any person administering the esere bean, whether the person taking it dies or not, shall be conside~d guilty of murder, and shall suffer death.
CHRONOUXY OF PHYSOSTIGMA VENENOSUM
Article four: Every person takiig the esere bean willfully, either for the purpose of committing suicide, or for the purpose of attempting to prove their innocence of any crime of which they may have been accused, shall be considered guilty of ATTEMPTED MURDER AND SHALL BE BANlSHED FROM THE COUNRY.
Even today the laws of Nigeria forbid the possession or use of the Calabar bean
The scientific exploration of the Calabar bean s t a n d in Edinburgh in 1846 where the keeper of the Royal Botanical Gardens, John Hutton Balfour (1808-1884) had contact with the Scottish missionaries of Old Calabar, especially with the reverend Hope Mastemn Waddell (1804.1895) who brought Calabar beans to Edinburgh where they grcw in Balfour's garden but never flowered. An Edinburgh toxicologist, Sir Robert Christison (1797-1882) was the f i t to describe the effects of the bean in an experiment on himself which he published in the Monthly Journal of Medicine (London) in 1855 under the title "On the Properties of the Ordeal Bean of Old Calabar." His doses in two experiments were fust six then fortyeight grains of the powder of ground Calabar beans.
Christison's assistant and later successor (in 1877). Thomas Richard Fraser (1841 -1920 made the important discoveries that the local application of extracts from the Calabar bean to the eye hall led to miosis or contraction of the pupil, an effect which could be counteracted and prevented by atropine. Fraser thus became the discoverer of "The antagonism between the actions of active substances" which he published in the British Medical Journal in 1872. As early as 1863 Fraser had alerted his friend, the ophthalmic surgeon, Douglas Argyll Robertson (1837 Robertson ( -1909 , to the use of the Calabar bean in ophthalmic surgery. Robertson's interpretation of the contraction of the sphincter pupilhe was ahead of its time, because he regarded this effect as a stimulation of the ciliary nerves. In 1877 Ludwig Laqueur was the fust ophthalmologist to recommend physostigmine or eserine for the relief of glaucoma, because the alkaloid lowered inmaocular pressure temporarily or permanently.
The Discovery of Neurohumoral Transmission: Ph
'
Ono Loewi (1873 Loewi ( -1961 in 1911 observed that physostigmine increased the sensitivity of peripheral organs to elecmc stimulation. At that time the question, "How are nerves stimulated ? Elecmcally or chemically 1" could not be decided. The answer, literally, came in a dream thatLoewi had in 1921:
The night before Easter Sunday of that year (1921) I awoke, turned on the light and jotted down a few notes on a tiny slip of paper. Then I fell asleep again. It occurred to me at six o'clock in the morning that during the night I had written down something most important but I was unable to decipher the scrawl. The next night, at thtee o'clock, the idea returned. It was the design of an experiment to determine whether or not the hypothesis of chemical transmission that I had uttered seventeen years ago was correct I got up immediately, went to the laboratory, and performed a simple experiment on a frog heart according to the nocturnal design. I have to describe this experiment briefly since its results became the foundation of the theory of chemical transmission of the nervous impulse.
The h e m of two frogs were isolated, the fust with its nerves, the second without Both hearts were attached to Straub cannulas fdled with a little Ringer solution. The vagus nerve of the fust hem was stimulated for a few minutes. Then the Ringer solution that had been in the fust hem during the stimulation of the vagus was bansferred to the second hean It slowed and its beats diminished just as if its vagus had been stimulated. Similarly, when the accelerator nerve was stimulated and the Ringer from this period transferred, the second hem speeded up and its beats increased. These results unequivocally proved that the nerves do not influence the hem d i i t l y but liberate from their terminals specific chemical substances which, in their turn, cause the well-known modifications of the function of the heart characteristics of the stimulation of its nerves.
This experiment led to "one of the most remarkable communications in the history of science" (Bo Holmstedt), entitled "ijber humorale iJbertragbarkeit der Hermervenwirkung", published in Pfliigers Archiv der gesamten Physiologie in 1921. Based on earlier observations of Reid Hunt (1870 Hunt ( -1948 that the effects of acetylcholine were intensified by eserine or physostigmine, Loewi cautiously concluded that "acetylcholie, of all the substances examined, of being the natural neurohumoral transminer is the one most suggestive." Sir Henry Dale (1875 Dale ( -1968 added the missing liik to this chain of thought: "It seems not improbable that an esterase conuibutes to the removal of the active ester from the circulation and the restoration of the original condition of sensitivity." This was the fust mention of an esterase (enzyme) in connection with the brevity of action of acetylcholine. In the eleventh paper in his famous series, ' m e mechanism of the effect of physostigmine on acetylcholine*', Loewi gave this view its experimental basis.
Structure and Svnthesis of Phvsostiemine.
In order to understand this unique inhibitory activity of physostigmine on an important enzyme, the saucture of this alkaloid had to be known. After its isolation in pure and crystalline form in 1864, famous chemists, such as the brothers Polonovski (1893-l923), Stedman and Barger (1925 ). and Robert Robinson (1932 -1935 worked on its elucidation. The final proof of srmcture came when Percy Julian and Josef P i published a paper in 1935 entitled "The Complete Synthesis of Physostigmine" in which they state:
Physostigmine, the principal alkaloid of the Calabar bean, and long used as a drug, has, since its isolation by Jobst and Hesse 70 years ago, been the subject of numerous investigations. The determination of its constitution was rendered particularly diff~cult since its peculiar chemical saucture found no analog in other plant products of known composition .... Shortly after promising experiments in the diuection of (its synthesis )
were under way (in our laboratories) the work had to be interrupted and could only be resumedrecently. In the meantime, the fust of a series of ten papers dealing with the synthesis of Physostigmine, by Robinson and his collaborators, appeared and seemingly proved convincingly that the (course) suggested in our formulas could not he realized in practice. Our experiments, nevertheless, were continued and led to the successful synthesis of d,l-Eserethole .....
To our surprise, our (d, I-Eserethole) exhibited entirely different properties than those of a compound synthesized by Robinson and his co-workers and called "d,l-Eserethole". Likewise were all derivatives different. Inasmuch as our (optically) inactive material, subjected to characteristic reactions of Eserethole of natural origin, yielded perfectly analogous results, we expressed the belief that our product was the real d,l-Eserethole. This is now proved conclusively by synthesis of I-Eserethole, identical with the product of natural origin.
Friends of Percy Julian, such as his teacher at Harvard, Elmer Peter Kohler (1865 -1938 ), or Max Tishler (1906 -1989 , the president-to-beof Merck, Rahway, New Jersey, all held their breath, because here were two brash nwphyres challenging the work of Sir Robert Robinson (1886 -1975 , Nobel Prize 1947 an eminent British chemist But Julian was right and Robinson wrong. Telegrams of congratulations came from all parts of America, Europe and Asia. Julian's admires in Asia, even sixty years later, still praise his achievements and when Julian finally was issued his commemorative stamp on January 29, 1993, in the series "Black Heritage", this was duly noticed in Japan by the IateProfessorYoshio Ban : Although there have been more than half a dozen subsequent syntheses of physostigmine, Julian's classical approach, with some recent modifications, is still the best route to the synthetic alkaloid and, therefore, is duly remembered in the latest eulogy from Japan:
More recently there has been a gowing need for new derivatives of physostigmine in clinical oials and applications, and, therefore, has focused interest on synthesis on a larger scale. Like most natural products physostigmine has asymmetry or chirality and exists in the plant as the (laevorotatory) (-)-isomer. This natural form (optical (-)-isomer) is highly potent in inhibiting the endogenous cholinesterase enzymes, whereas the unnatural (+)-antipode is inactive, but has other useful properties. Total synthesis leads to a racemic mixture of both optical isomers which have to be separated (resolved) at the right stage by the right method. This problem was recently tackled and solved in a collaboration of the National Institutes of Health, Georgetown University and the Shanghai Institute of Organic Chemistry under the guidance of Arnold Brossi [cf." Heterocycles", Volume 36, 1279 (1993)l. The stage of resolution takes place early in the sequence of reactions, and the racemic precursor, oxindole-acetic acid, provides the optically pure intermediate.
In remembering Julian's synthesis (1935) his friend and collaborator Josef Pikl, since deceased, in a personal l e m to the author (1977) gives a vivid description of the research climate and the hard work that made the original total synthesis such a success:
Throughout the six years of our collaboration, we made a good team. Percy generated ideas faster than half a dozen people could critically review and test them. He also did most of the writing, did practically all of the analytical work, such as carbon-hydrogen analyses, and determination of active hydrogen with his Grignard machine, and helped with much of the dish-washing chores using a two foot diameter porcelain dish with hot sulfuric acid and nimc acid, unaware of the dangers of this method, outside of acid hums. When we were celebrating some progress or the receipt of a nice letter, we drove out about six miles to the crossing of the Transcontinental Route 40 where there was a small snack restaurant. Usually, however, we stayed up to 11-12 o'clock in the laboratory so that we heard some complaints of burning too much midnight oil ! Carbamylation of the AcetylchoWterase by Physostigmine. 
Physostigmine
Catalytic mechanism of acetylcholinesterase T h e ( + O -P h v s o s t i~c t s aeainst Nerve Gases.
The slow rate of hydrolysis of carbamoly-AChE intermediates is far surpassed by the almost irreversible combination of the so-called "nerve gases", such as Tabun, Sarin, Parathion or di-isopropylfluorophosphate (DIPF).
DIPF-inhibited enzyme Parathion
Organic phosphate inhibitors of acetylcholinesterase During the years of the cold war with all the anxiety about chemical warfare the search for an effective antidote led to a surprising discovery: The unnatural (+)-physostigmine had been known for some time (1970, 1993) but it acquired a new importance when, in conjunction with ampine, the well-known basic principle of the Belladonna planc it offered prophylactic protection, less through interaction with AChE, but by combining with a special site on the (nicotinic) acetylcholine receptor site. Thus (+)-physostigmine is no longer a useless byproduct of the total synthesis of the natural base, but useful for new and exciting studies of the AChE-receptor (Edson X. Albuquerque, University of Maryland W c a l Center).
Phvsostiemine Theraov in Mvasthenia Gravis.
There is a disorder of neuromuscular function, clinically observable through muscular debility, fatigue and exhaustion of part or a l l of the muscular system, thought to be due to the presence of antibodies to (nicotinic) acetylcholine.receptors at the neuromuscular junctions, in other words an auto-immune disorder. This disease afflicts at least one in 10,000 persons and can occur at virtually any age, but is observed more often in women in their twenties and thirties, and in men in their fifties and sixties. It is a long and disabling disease whose fundamental defect is a decrease in the number of available acetylcholine receptors at postsynaptic muscle membranes which are altered by being flattened and with much fewer folds than normal. Although acetylcholine release proceeds in a normal way from the pre-synaptic terminal, it produces only a small end-plate potential which often fails to cause depolarization and does not trigger muscle fibers into contraction. Whereas the clinical symptoms of thii syndrome have been known for more than a hundred years, the fust publication linking this disorder with physostigmine did not appear until 1934 in Lancet under the title "Trement of Myasrhenia Gravis with Physostigmine." The author, Mary Walker, had received her medical d e p at the University of Edinburgh, the place that is s o intimately connected with the history of physostigmine. The fust positive clinical results are best described in her own words:
The abnormal fatigability in Mymthenia Gravis has been thought to be due to curare-like poisoning of the motor nerve-endings or of the "myoneural junctions" in the affected muscles. It occurred to me recently that it would be worth-while to ! q the effect of physostigmine, a partial antagonist to curare, on a case of Myasrhenia Gravis at present in St. Alfege's Hospital, in the hope that it would counteract the effect of the unknown substance which might be exerting a curare-like effect on the myoneurd junctions. I found that hypodmic injections of physostigmine salicylate did have a saiking though temporary effect.
Subsequent improvements with other patients were refereed to as "the miracle at St. Alfeges", the hospital in Greenwich, England, where Dr. Walker was working. In 1935 she was awarded the gold medal of medicine from the University of Edinburgh; in 1955 she became an honorary member of the Myasthenia p v i s Foundation, an organizer of frequent international symposia.
Drugs that inhibit ACbE and increase the physiological half-life time of released acetylcholine for longer interaction with the limited number of acetylcholine receptors improve muscle strength and remain, to the present day, the major therapeutic appmach. Pyridostigmine and Neostigmine, two analogs of physostigmine that do not enter the brain, are two of the most prescribed inhibitors of AChE and provide relief for clinical symptoms of Myasrhenia Gravis.
. .
Phvsoshgmu~e Analoes and Alzhcirner's Disease
The loss of memory during senescence and cognitive deficits, what is referred to as senility, is a phenomenon that the German neurologistAlois Alzheimer (18641915) observed in people as young as 40 years and calledpresenile dementia In its severe form this syndrome is characterized by cortical atrophy and major histological degenerative changes in the brain. The disease is the fourth leading cause of death in Western Societies, alTlicting some 4 million American and an additional seven million in other developed countries.
Mental disorders, such as schizophrenia, mostly have a biochemical or neurophysiological etiology and their study has always led to new insights into normal and abnormal metabolism of neumhumoral uansmitters. Thus, attention has been focused on the role of the cholinergic system in the behavior of normal humans compared with Alzheimer patients: it is now recognized that deficiences in the cholinergic system may account for some of the cognitive deficits, i.e., loss of memory, aphasia, etc., found in Alzheimer patients. Early in the course of the disorder, the forebrain cholinergic system of neurons, which activates crucial brain areas by the release of acetylcholine, becomes progressively impaired. Yet, these neurons are critical for learning and memory as evidenced by their transient inhibition, either by drugs in man, or their experimental desmction in animals, both leading to profound amnesia. Degeneration of this neuronal system is one of the first observable changes that occurs during Alzheimer's disease, and the degree of degeneration is directly correlated with the severity of memory impairment.
Neuorchemcial studies indicate that, although there is a dramatic loss of presynaptic elements of the cholinergic system in brain, especially in the hippocampus and cortex, brain areas associated with memory and cognition. The postsynaptic elements remain relatively intact except late in the disease when virtually all neurotransmitters are at lower level and there is a loss of brain matter.
Understandably the search for therapeutic agents immediately concentrated on suitable inhibitors of AChE, such as physostigmine, the alkaloid galanthamine or its quaternary diiethylcarbamoyl analog, or 5-aminotetrahydroacridine (Tacrine or Cognex). Such an inhibitor should satisfy the following requirements: Galanthamine Deoxydemethyllycoramine N,N-dimethylcarbarnate methiodide 1. produce a long-term and selective acetylcholinesterase inhibition in brain with a steady-state phase of increased cortical acetylcholine.
2. not inhibit acetylcholine synthesis or its release in nerve endings.
3. produce no or only mild side effects at therapeutic doses, Both physostigmine and tacrine have been administered to Alzheimer patients to assess their therapeutic value as inhibitors of AChE. Both drugs improved cognition in the majority of patients; however, they have side effects, such as shon duration of action, high toxicity and unselective action on both forms of the enzyme, AChE and BChE. Cognitive improvement is commensurate with the level of inhibition of AChE. Unfortunately, for both drugs, peripheral side effects became dose-limiting early in the treabnent, a limitation which has hampered the hue evaluation of ACE-inhibitors for Alzheimer's disease. Other candidates for experimental therapy, such as the highly lipophilic heptastigmine, an N-heptykarbamylphysostigmine, causes agranulocytosis with the consequence that its climical hials have been discontinued.
Here we return to Julian's fust total synthesis and its recent improvement (vide infra) and concentrate on phenylcarbamates of physostigmine:
Phenserine Tolserine P h e n s e~e , as a result of its physico-chemical properties, has optimal characteristics for central nervous system (CNS) activity. The substitution of the methylcarbamyl of physostigmine by the phenylcarbamyl gmup increased its lipophilicity seven-fold and hence its ability to cross the blood-brain banier.
The Action of Anticholinestrases. and Specificallv of Phenserine. in Alzheimer's Disease.
In Alzheimer's disease, cholinergic inputs to higher brain centers are reduced in number, leading to a reduced release of neurotransmitter, acetylcholine, and, as a consequence, a reduced stimulation of postsynaptic elements. By inhibiting acetylcholinesterase (localized on the postsynaptic cell surface) and blocking newoaansmitter destruction, anti-cholimesterases prolong the life of acetylcholine, restoring levels in the synapse. Phenserine is delivered preferentially to the brain, where it selectively inhibits acetylcholinesterase, and therefae is a promising drug candidate for the matment of Alzheimer's disease.
Whereas phyosostigmine and tanine enter the brain from the systemic circulation and maintain a brainlplasma ratio of 1:1, phenserine and its analogs achieve and maintain ten-fold higher brain levels compared with plasma; they act selectively on ACE rather than BChE, have minimal peripheral side-effects and a duration of inhibition of AChE of more than 8 hours compared with 30 minutes for physostigmine. Interestingly, once the enzyme has been inhibited, a continued presence of the drug for pharmacological activity is no longer required and phenserine and its analogs disappear rapidly from the body. The long duration of action of these compounds, their phmaco-dynamics, results in a regimen of low dosing frequency and their rapid clearance (phmaco-kinetics) from the blood stream with a low exposure of the body to the drug, two highly desirable amibutes for a drug candidate for the elderly generation.
Not only do brain levels of acetylcholine rise in the rat brain after administration of phenserine, but such an unusually wide "therapeutic window" has not been seen in other drugs when it comes to behavioral tests as a cognition enhancer in rats. Specifically, phenserine improves the ability of young and aged animals to learn a complex maze pattern in which correct choices are required to negotiate through i t The improved memory in aged rats not only suggests that the drug could be useful in Alzheimer's disease but also as a potential remedy in age-associated memory disorders.
Physostigmine, the fust alkaloid proven to act through inhibition of an enzyme, and its analogs are used as miotics in glaucoma, as therapeutic agents in mycsthenia gravir, intestinal paralysis, antagonists of curare in anaesthesiology, as antidotes in aeopine poisoning, and now in the form of phenserine or tolserine as promising candidates for the eeatment of Alzheimer patients. If Percy J u l i were alive and could observe the growing importance of physostigmine and the blessing that his seminal fust total synthesis left to coming generations, he would probably exclaim with Macbeth: "If you can look into the seeds of time and say which grain will gow and which will not."
-m -the Bridee to *masterol and the Sex Hormones.
Julian's fust U. S. Patent 2,218,971 was granted on October 22, 1940 and entitled "Recovery of Sterols." MaxTishler, President of Merck to be, in 1965 described the chain of events:
And then came one of those bits of "accidental chemisq." In auempts to isolate Geneserin, a companion alkaloid of Physostigmine, from the Calabar bean (Physostigma venenoswn), Julian had fist extracted the oil from this rather lovely bean. ?he oil had been washed with dilute acid and then with water, and was set aside wet. On examining it some weeks later, glistening small crystals had separated. They were carefully separated from the oil and found to be a hydrate, which upon losing its water, was again soluble in the oil. After careful recrystallization of the minute quantity of dehydrated material, microanalysis showed the formula C29H480. A literature search showed that it was the sterol, stigmasterol, named after the plant physostigma venenosum, from which Windaus and Nauth had separated it 29 years before.
Butenandt and his collaborators Mamoli, Fernholz, Westphal, had converted stigmasterol into the sex hormones pregnenolone and progesterone, hormones of gat commercial value. The most convenient source for the isolation of stigmasterol was soy bean oil. When Julian asked the Glidden Company in Chicago for a 5-gallon sample of soy bean oil, Mr. W. 1. O'Brien, the Vice President offered him the position of Glidden's Assistant Director of Research of the Soya Product Division, an offer that J u l i i gladly accepted in 1936.
In the following 4 years this Soya Products Division became Glidden's most profitable single entity as evidenced by Julian's many patents, such as "Lecithin Granules" from Soya Phosphatides, or liquid shortening and Durkee's edible emulsifers and new animal feeds.
And then came the sequence to the happy accident thatTishler referred to: One day workers called Julian, as chief trouble shooter, to advise what should he done with a 100,000 gallon tank of purified soy bean oil into which water had leaked and which contained a mass of white solid. Julian remembered his experience at DePauw, had the whole tank centrifuged and obtained about 15% of mixed soya sterols, amounting to about 100 pounds of sterols daily with a value of about $10,000 in 1940. Julian lost no time and, on an unprecedented industrial scale, ozonized 100 pounds daily of sterol dibromides to end up with pure progesterone, pure female sex hormone. In 1948 Philip Hench (1896 -1965 ), Edward Kendall (1886 -1972 . .
Pregnanediol Pregnanedione
(for your confidential information our accountants have just given me our sales for the fust 10 months of our fiscal year ending August 31st, and they show close to 1.5 million dollars), I am again able to turn back to some of the things which have interested me, of course, most of my life. I still am far from being out of the woods. I need more men badly, among them a good plant manager and good production superintendent, several research men, two more Ph.D.'s at least and three or four junior assistants, a new personal assistant, etc., etc. Incidentally, in this connection, I would appreciate it if you know of any young men who might like to join our organization. As you can probably imagine, we have a very ambitious research program going on in the steroid f~l d , some of which will, no doubt, be published shortly, now that the necessary patents and the necessary protections for our clients have all been cared for. You may also be interested to know that we import from our plantations and our factory in Central America, Dioscorea root, process it into Diosgenin, and into 16-Dehydropregnenolone here at Julian Laboratories, and thus have become very competitive, and the field a bit overcrowded, we have enjoyed a very good business, and are looking forward to double our sales for the coming year, now that our raw material supply is adequate. I hope that in the not-todistant future, you can visit our laboratories here and see our research and production set-up."
While he was alive, and even posthumously, Julian was rewarded by 19 honorary degrees, one of them at
Oberlin college in June 1964, with the following eulogy:
In these days in which specialization sometimes seems to dominate, I have the privilege of presenting a man who illustrates the general usefulness of an educated mind. In sequence as chemisuy teacher, teacher and researcher, researcher and administrator, and entrepreneur and researcher, Percy Julian joined several careers through his continuing interest in natural materials from plants.
He demonstrated his chemical competence and creative imagination in applied chemisuy by securing a number of patents for the making of desired substances from the plant products, but he also kept on publishing in pure chemistry an impressive series of papers on indoles, sterols and steroids, and conjugated systems. Finally, he founded two f m s through which he could apply his scientific knowledge, inventive skill, and judgment to recover large quantities of intermediate substances from soya beans and other plants and to make from them hormones and other drugs at low cost We honor h i for his humane objectives.
